Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 28 | 2022 | 1173 | 2.630 |
Why?
|
| Heart, Artificial | 6 | 2018 | 77 | 1.370 |
Why?
|
| Heart Transplantation | 12 | 2022 | 885 | 1.270 |
Why?
|
| Heart Failure | 18 | 2022 | 2523 | 1.240 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2019 | 430 | 0.760 |
Why?
|
| Models, Cardiovascular | 3 | 2018 | 202 | 0.760 |
Why?
|
| Cardiomyopathies | 2 | 2019 | 601 | 0.510 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2014 | 300 | 0.440 |
Why?
|
| Assisted Circulation | 2 | 2014 | 37 | 0.380 |
Why?
|
| Thrombosis | 3 | 2014 | 782 | 0.350 |
Why?
|
| Heart Ventricles | 4 | 2017 | 847 | 0.340 |
Why?
|
| Prosthesis Design | 6 | 2019 | 752 | 0.340 |
Why?
|
| Receptors, Adrenergic, beta | 2 | 2008 | 97 | 0.340 |
Why?
|
| Pulsatile Flow | 4 | 2016 | 130 | 0.310 |
Why?
|
| Plasma Exchange | 1 | 2008 | 117 | 0.290 |
Why?
|
| Pulse | 1 | 2006 | 31 | 0.290 |
Why?
|
| Myocardium | 4 | 2018 | 1294 | 0.280 |
Why?
|
| Atrial Natriuretic Factor | 2 | 2005 | 68 | 0.270 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 315 | 0.240 |
Why?
|
| Jehovah's Witnesses | 1 | 2023 | 21 | 0.230 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2005 | 237 | 0.220 |
Why?
|
| Aorta | 1 | 2006 | 690 | 0.210 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2010 | 1234 | 0.210 |
Why?
|
| Bioprosthesis | 3 | 2018 | 167 | 0.210 |
Why?
|
| Myocardial Ischemia | 2 | 2005 | 433 | 0.210 |
Why?
|
| Preoperative Care | 1 | 2008 | 1529 | 0.200 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2005 | 1539 | 0.170 |
Why?
|
| Bioartificial Organs | 1 | 2018 | 12 | 0.170 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2019 | 72 | 0.160 |
Why?
|
| Hemodynamics | 4 | 2016 | 941 | 0.160 |
Why?
|
| Materials Testing | 1 | 2018 | 116 | 0.160 |
Why?
|
| Treatment Outcome | 13 | 2022 | 32987 | 0.150 |
Why?
|
| Renal Replacement Therapy | 1 | 2019 | 137 | 0.150 |
Why?
|
| Tissue Scaffolds | 1 | 2018 | 136 | 0.150 |
Why?
|
| Anemia | 1 | 2023 | 691 | 0.150 |
Why?
|
| Middle Aged | 21 | 2019 | 86445 | 0.140 |
Why?
|
| Male | 26 | 2022 | 123277 | 0.140 |
Why?
|
| Tissue Engineering | 1 | 2018 | 270 | 0.140 |
Why?
|
| Equipment Design | 4 | 2016 | 1207 | 0.130 |
Why?
|
| Hemorheology | 1 | 2015 | 45 | 0.130 |
Why?
|
| Prosthesis Implantation | 1 | 2017 | 265 | 0.130 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 547 | 0.130 |
Why?
|
| Humans | 34 | 2023 | 262210 | 0.130 |
Why?
|
| Cattle | 4 | 2018 | 783 | 0.130 |
Why?
|
| Capillary Permeability | 1 | 2015 | 114 | 0.130 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2014 | 43 | 0.120 |
Why?
|
| Aged | 15 | 2019 | 70322 | 0.110 |
Why?
|
| Female | 23 | 2022 | 142240 | 0.110 |
Why?
|
| Cardiomegaly | 1 | 2014 | 198 | 0.110 |
Why?
|
| Adult | 21 | 2022 | 78087 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 768 | 0.110 |
Why?
|
| Myocytes, Cardiac | 2 | 2018 | 783 | 0.110 |
Why?
|
| Thromboembolism | 2 | 2010 | 158 | 0.100 |
Why?
|
| Survival Rate | 4 | 2019 | 12236 | 0.100 |
Why?
|
| Hemorrhage | 2 | 2013 | 713 | 0.100 |
Why?
|
| Recovery of Function | 2 | 2012 | 718 | 0.100 |
Why?
|
| Heart Defects, Congenital | 1 | 2022 | 1683 | 0.100 |
Why?
|
| Ventricular Function, Left | 2 | 2012 | 600 | 0.100 |
Why?
|
| Muscle Proteins | 1 | 2014 | 551 | 0.090 |
Why?
|
| Time Factors | 5 | 2010 | 12967 | 0.090 |
Why?
|
| Miniaturization | 1 | 2009 | 47 | 0.090 |
Why?
|
| Stroke | 3 | 2013 | 1155 | 0.090 |
Why?
|
| Transposition of Great Vessels | 1 | 2010 | 124 | 0.090 |
Why?
|
| Long-Term Care | 1 | 2009 | 83 | 0.080 |
Why?
|
| Retrospective Studies | 9 | 2022 | 38006 | 0.080 |
Why?
|
| Canada | 1 | 2010 | 431 | 0.080 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 2008 | 15 | 0.080 |
Why?
|
| Bleeding Time | 1 | 2008 | 14 | 0.080 |
Why?
|
| Prothrombin Time | 1 | 2008 | 44 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2013 | 9293 | 0.080 |
Why?
|
| Partial Thromboplastin Time | 1 | 2008 | 55 | 0.080 |
Why?
|
| Shock, Cardiogenic | 1 | 2010 | 250 | 0.080 |
Why?
|
| Thoracotomy | 1 | 2009 | 220 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 1329 | 0.070 |
Why?
|
| Bilirubin | 1 | 2008 | 221 | 0.070 |
Why?
|
| Postoperative Hemorrhage | 1 | 2008 | 163 | 0.070 |
Why?
|
| Sheep | 1 | 2006 | 258 | 0.070 |
Why?
|
| Hemoglobins | 1 | 2008 | 477 | 0.070 |
Why?
|
| Cause of Death | 2 | 2009 | 755 | 0.070 |
Why?
|
| Creatinine | 1 | 2008 | 541 | 0.070 |
Why?
|
| United States | 5 | 2022 | 15561 | 0.070 |
Why?
|
| Electrophoresis | 1 | 2005 | 60 | 0.070 |
Why?
|
| Brachiocephalic Trunk | 1 | 2005 | 43 | 0.070 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2008 | 423 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 6560 | 0.060 |
Why?
|
| Hemolysis | 2 | 2018 | 126 | 0.060 |
Why?
|
| Blood Flow Velocity | 1 | 2006 | 475 | 0.060 |
Why?
|
| Young Adult | 6 | 2013 | 21474 | 0.060 |
Why?
|
| Blood Transfusion | 2 | 2023 | 585 | 0.060 |
Why?
|
| Antigens, CD | 2 | 2015 | 1382 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2009 | 788 | 0.060 |
Why?
|
| Adolescent | 8 | 2013 | 31257 | 0.060 |
Why?
|
| Caveolins | 1 | 2003 | 73 | 0.060 |
Why?
|
| Device Removal | 1 | 2005 | 339 | 0.050 |
Why?
|
| Postoperative Complications | 2 | 2017 | 5565 | 0.050 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2003 | 89 | 0.050 |
Why?
|
| Heart Valve Prosthesis | 2 | 2003 | 386 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2005 | 3537 | 0.050 |
Why?
|
| Genes, erbB-2 | 1 | 2002 | 229 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 544 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2010 | 9186 | 0.050 |
Why?
|
| Aged, 80 and over | 5 | 2013 | 29997 | 0.050 |
Why?
|
| Prosthesis Failure | 2 | 2012 | 210 | 0.040 |
Why?
|
| Animals | 6 | 2018 | 59534 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2003 | 582 | 0.040 |
Why?
|
| Quality of Life | 4 | 2022 | 4577 | 0.040 |
Why?
|
| Proportional Hazards Models | 3 | 2017 | 5008 | 0.040 |
Why?
|
| Outpatients | 2 | 2013 | 461 | 0.040 |
Why?
|
| Platelet Activation | 1 | 2018 | 116 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2005 | 4348 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 1071 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2023 | 2917 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 10009 | 0.040 |
Why?
|
| Biopsy | 1 | 2005 | 3457 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 1015 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2003 | 737 | 0.040 |
Why?
|
| Benchmarking | 1 | 2018 | 272 | 0.030 |
Why?
|
| Pressure | 1 | 2016 | 216 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 2018 | 334 | 0.030 |
Why?
|
| Microcirculation | 1 | 2016 | 200 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2018 | 1003 | 0.030 |
Why?
|
| Adherens Junctions | 1 | 2015 | 20 | 0.030 |
Why?
|
| Transplantation, Heterotopic | 1 | 2014 | 41 | 0.030 |
Why?
|
| Swine | 1 | 2018 | 1552 | 0.030 |
Why?
|
| Microvessels | 1 | 2015 | 136 | 0.030 |
Why?
|
| Blood Volume | 1 | 2014 | 102 | 0.030 |
Why?
|
| Gene Expression | 1 | 2002 | 3564 | 0.030 |
Why?
|
| Vascular Resistance | 1 | 2014 | 197 | 0.030 |
Why?
|
| NFATC Transcription Factors | 1 | 2014 | 99 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2002 | 2296 | 0.030 |
Why?
|
| Child | 4 | 2022 | 29135 | 0.030 |
Why?
|
| Feedback | 1 | 2014 | 206 | 0.030 |
Why?
|
| Biomarkers | 1 | 2005 | 5049 | 0.030 |
Why?
|
| Edema | 1 | 2015 | 267 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 208 | 0.030 |
Why?
|
| Calcineurin | 1 | 2014 | 133 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2013 | 344 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2018 | 1047 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2014 | 245 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 371 | 0.030 |
Why?
|
| Cadherins | 1 | 2015 | 663 | 0.030 |
Why?
|
| Retreatment | 1 | 2012 | 452 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2015 | 876 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2016 | 1466 | 0.020 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2010 | 125 | 0.020 |
Why?
|
| Actuarial Analysis | 1 | 2009 | 159 | 0.020 |
Why?
|
| International Normalized Ratio | 1 | 2009 | 48 | 0.020 |
Why?
|
| Ventricular Function, Right | 1 | 2010 | 111 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2014 | 1532 | 0.020 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2010 | 304 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2010 | 828 | 0.020 |
Why?
|
| Warfarin | 1 | 2009 | 152 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 1275 | 0.020 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 257 | 0.020 |
Why?
|
| Heart | 1 | 2014 | 1225 | 0.020 |
Why?
|
| Software | 1 | 2014 | 1325 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2009 | 324 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 12914 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2009 | 574 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2003 | 3637 | 0.020 |
Why?
|
| Aspirin | 1 | 2009 | 455 | 0.020 |
Why?
|
| Registries | 1 | 2013 | 2187 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2012 | 14904 | 0.020 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2005 | 160 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 5680 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 1364 | 0.010 |
Why?
|
| Caveolin 2 | 1 | 2003 | 5 | 0.010 |
Why?
|
| Age Factors | 1 | 2013 | 5386 | 0.010 |
Why?
|
| Caveolin 3 | 1 | 2003 | 12 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2010 | 2801 | 0.010 |
Why?
|
| Mitral Valve Stenosis | 1 | 1983 | 50 | 0.010 |
Why?
|
| CD36 Antigens | 1 | 2003 | 53 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2005 | 756 | 0.010 |
Why?
|
| Probability | 1 | 2005 | 868 | 0.010 |
Why?
|
| Waiting Lists | 1 | 2005 | 259 | 0.010 |
Why?
|
| Receptor, ErbB-4 | 1 | 2002 | 23 | 0.010 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2002 | 24 | 0.010 |
Why?
|
| Reference Values | 1 | 2005 | 1098 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 4028 | 0.010 |
Why?
|
| Caveolin 1 | 1 | 2003 | 203 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2003 | 1055 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 2005 | 708 | 0.010 |
Why?
|
| Calcinosis | 1 | 1983 | 425 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2005 | 623 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6219 | 0.010 |
Why?
|
| Palliative Care | 1 | 2010 | 2035 | 0.010 |
Why?
|
| Critical Care | 1 | 2005 | 771 | 0.010 |
Why?
|
| Aortic Valve Stenosis | 1 | 1983 | 476 | 0.010 |
Why?
|
| Risk Factors | 1 | 2013 | 17605 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 4977 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2002 | 2449 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 11978 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 3127 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 6132 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 34438 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 7558 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2005 | 6891 | 0.010 |
Why?
|